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We retrospectively reviewed patients who underwent radical or partial nephrectomy and were followed-
up in Oji General Hospital from 1992 through 2012. A total of 6 patients had disease recurrence in the
pancreas during follow-up. We investigated their clinical features and treatment outcomes. The median
age at diagnosis was 75 years. The median interval from nephrectomy to the detection of pancreatic
metastasis was 114 months. As local therapy for metastasis, surgical resection was selected for 4 patients.
On the other hand, administration of medication, including interferon alpha and sunitinib was selected for 2
patients with other simultaneous metastatic sites. One of the 4 patients with surgical resection had disease
recurrence in the residual pancreas and needed additional excision. At the median follow-up of 38 months
after treatment of pancreatic metastasis, one patient remained alive without evidence of disease, 3 patients
were alive with recurrent disease, and 2 patients had died of the disease.
(Hinyokika Kiyo 60 : 105-108, 2014)
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結 果
















は最大で 42 mm であった．
Table 3 に膵転移同定後の臨床経過を示す． 5例で
病理組織学的診断がなされた． 4例は転移巣摘除によ
るもので， 1例は超音波内視鏡下穿刺吸引術での診断
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Table 1. Status of the patients before diagnosis of pancreatic metastasis
Case
No Age* Sex
Details of treatment for primary tumor Details of other metastasis before detection of pancreatic metastasis
Procedure Pathology Site Time at detection** Treatment formetastasis
Status just before
pancreatic metastasis
1 67 F Lt Nx pT1b, clear cell, G1, v0 Disease free
2 57 M Lt PNx pT1a, clear cell, G1
＞G2,
v0 Lung 66 VATS Disease free
3 82 M Rt Nx pT2, clear cell, G1, vx Lung 96 IFN Lung metastasis
4 79 M Rt Nx
＋
Rt Adx pT2, clear cell, G2
＞1, vx
Lt adrenal 114 Lt Adx
Lung 151 IFN Lung metastasis
5 73 M Rt Nx pT1a, clear cell, G1, v1 Disease free
6 77 F Rt Nx pT2, clear cell, G1, v0 Disease free
* Age at diagnosis of pancreas metastasis, ** Duration from surgery for primary tumor to detection metastasis, month. M : male, F :
female, Nx : radical nephrectomy, Adx : adrenalectomy, VATS : video-assisted thoracic surgery.
Table 2. Status of pancreatic metastasis
Case No Time at detection* Subjective symptom Site at pancreas (number) Size (mm)
1 68 None Head (1), Body (1), Tail (1) 12, 10, 30
2
83 Abdominal pain Head (1) 16
114 Abdominal pain Tail (1) 7
3 115 None Head (1) 15
4 175 None Head (1), Tail (2) 21, 20, 21
5 79 None Body (1) 37
6 119 None Body (2), Tail (1) 10, 42, 30
* Duration from surgery for primary tumor to detection pancreatic metastasis, month.
Table 3. Clinical outcomes of the patients with pancreatic metastasis
Case
No Treatment of pancreatic metastasis
Details of other site of metastasis
Follow-




56 Alive with cancer
Bone (tibia, calcaneus) XRT (36, 39 Gy)
2 Pancreatoduodenectomy recurrence of resi-dual pancreas and surgical resection Lung, thyroid
VATS,
hemithyroidectomy 52 Alive with cancer
3 Tumor enucleation Lung IFN 24 Cancer death
4 Medication (IFN) Lung, Liver IFN 57 Cancer death
5 Medication (sunitinib→everolimus) Liver Sunitinib→Everolimus 22 Alive with cancer
6 Distal pancreatectomy None 9 No evidence of disease
* Time from detection of pancreatic metastasis to ﬁnal visit, month.
核出術を施行した．核出術後の膵再発は認めなかっ
た．手術治療 4例は，周術期に重篤な合併症は認めな








始 1コース目の副作用として，血小板減少 grade 2，
好中球減少 grade 2，手足症候群 grade 1，発熱 grade 1
を認めた．いずれも軽度であったが，以後の治療は
25 mg/日を 2 週投与， 2 週休薬のスケジュールで継
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続した．合計16コースまで施行したが，膵および肝転
移巣の増大を認めたため，everolimus に変更した．開
始時より血清クレアチニン増加 grade 2，貧血 grade 3
を認めていたため，5 mg/日より開始した．開始 1週
間で，高尿酸血症 grade 2 の副作用を認め，投与開始






































































報告では， 6 症例に sunitinib を投与し，観察期間中
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